Combination of Tadalafil and Finasteride for the Treatment of Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Commercialization of the Prescribing Cascade-Reference-Cited by-同舟云学术

Combination of Tadalafil and Finasteride for the Treatment of Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Commercialization of the Prescribing Cascade

Published:2022-04 Issue:4 Volume:81 Page:323-324
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Nguyen David-Dan,Trinh Quoc-Dien,Bhojani Naeem

Funder

Bayer

Pfizer

Astellas Pharma US

Publisher

Elsevier BV

Reference10 articles.

1. Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia;Casabé;J Urol,2014

2. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I—initial work-up and medical management;Lerner;J Urol,2021

3. EAU guidelines: management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO);Gravas,2019

4. Combination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focus;Elkelany;Ther Clin Risk Manag,2015

5. The effect of finasteride in men with benign prostatic hyperplasia;Gormley;N Engl J Med,1992

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and development of steroidal enzyme inhibitors as anti-cancer drugs: state-of-the-art and future perspectives;Journal of Enzyme Inhibition and Medicinal Chemistry;2025-04-02

2. Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: Tukey's test;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-01

3. Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride;Journal of Personalized Medicine;2023-10-31

4. Synchronous fluorescence as a green and selective method for the simultaneous determination of finasteride and tadalafil in dosage form and spiked human plasma;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2023-10

5. Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules;BMC Chemistry;2022-07-29